Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3690371013 | Rivastigmine in transdermal dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3690372018 | Product containing rivastigmine in transdermal dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3690373011 | Product containing rivastigmine in transdermal dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3711789012 | Product containing rivastigmine in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3711790015 | Rivastigmine-containing product in transdermal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing rivastigmine in transdermal dose form (medicinal product form) | Plays role | Antidementia therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing rivastigmine in transdermal dose form (medicinal product form) | est un(e) (attribut) | Medicinal product acting as antidementia agent (product) | true | Inferred relationship | Some | ||
| Product containing rivastigmine in transdermal dose form (medicinal product form) | a une forme pharmaceutique (attribut) | forme transdermique (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Product containing rivastigmine in transdermal dose form (medicinal product form) | a pour principe actif (attribut) | Rivastigmine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing rivastigmine in transdermal dose form (medicinal product form) | est un(e) (attribut) | Product manufactured as transdermal dose form (product) | true | Inferred relationship | Some | ||
| Product containing rivastigmine in transdermal dose form (medicinal product form) | est un(e) (attribut) | rivastigmine | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only rivastigmine in transdermal dose form (medicinal product form) | est un(e) (attribut) | True | Product containing rivastigmine in transdermal dose form (medicinal product form) | Inferred relationship | Some | |
| Rivastigmine 9.5mg/24 hours transdermal patch (product) | est un(e) (attribut) | False | Product containing rivastigmine in transdermal dose form (medicinal product form) | Inferred relationship | Some | |
| Rivastigmine 4.6mg/24 hours transdermal patch (product) | est un(e) (attribut) | False | Product containing rivastigmine in transdermal dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR